MWM
AVDL

Modera Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Modera Wealth Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-160,100
Closed -$1.68M – 610
2024
Q4 		$1.68M Buy
+160,100
New +$1.94M 0.02% 263

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Modera Wealth Management's AVDL Position: Q1 2026 in Review

Modera Wealth Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 558,972 shares — an estimated $12M sold.

Modera Wealth Management first reported a position in AVDL in Q2 2022 and held it in 15 quarters. The position peaked at $12M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Modera Wealth Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Modera Wealth Management sold 558,972 Avadel Pharmaceuticals shares in Q1 2026, an estimated $12M.
  • Modera Wealth Management first reported a position in Avadel Pharmaceuticals in Q2 2022 and held it in 15 quarters.
  • Modera Wealth Management's Avadel Pharmaceuticals position peaked at $12M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Modera Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.